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Using an in-vitro biofilm model 
to assess the virulence potential 
of Bacterial Vaginosis or non-
Bacterial Vaginosis Gardnerella 
vaginalis isolates
Joana Castro1,2, Patrícia Alves1, Cármen Sousa1, Tatiana Cereija1, Ângela França1, 
Kimberly K. Jefferson3 & Nuno Cerca1
Gardnerella vaginalis is the most common species found in bacterial vaginosis (BV). However, it 
is also present in a significant proportion of healthy women and G. vaginalis vaginal colonization 
does not always lead to BV. In an effort to better understand the differences between G. vaginalis 
isolated from women with a positive (BV) versus a negative (non-BV) diagnosis of BV, we compared 
the virulence potential of 7 BV and 7 non-BV G. vaginalis isolates and assessed the virulence factors 
related to biofilm formation, namely: initial adhesion and cytotoxic effect, biofilm accumulation, 
susceptibility to antibiotics, and transcript levels of the known vaginolysin, and sialidase genes. 
Furthermore, we also determined the ability of G. vaginalis to displace lactobacilli previously 
adhered to HeLa cells. Our results showed that non-BV strains were less virulent than BV strains, 
as suggested by the lower cytotoxicity and initial adhesion to Hela cells. Significant differences 
in expression of known virulence genes were also detected, further suggesting a higher virulence 
potential of the BV associated G. vaginalis. Importantly, we demonstrated that BV associated G. 
vaginalis were able to displace pre-coated vaginal protective lactobacilli and we hypothesize this to 
be a trigger for BV development.
Bacterial vaginosis (BV) is the most common vaginal disorder worldwide in women of reproductive 
age1. It is often characterized by the loss of normal vaginal flora, particularly Lactobacillus species, and 
overgrowth of anaerobes such as Gardnerella vaginalis2,3. While other bacterial species are also com-
mon, their role in BV is not clear and we recently demonstrated that G. vaginalis had significant higher 
virulence potential than other 29 BV associated species4. However, despite being the most prevalent 
and virulent species found in BV, G. vaginalis can also be a part of the vaginal microbiota in healthy 
women5,6. Consequently, there has been much debate in the literature concerning the contribution of 
G. vaginalis to the etiology of BV4,7. Reports indicate that G. vaginalis is a highly diverse taxon, both 
phenotypically and genotypically8,9. 8 biotypes of G. vaginalis have been identified by Piot9 based on 
the presence of β -galactosidase, lipase and hippurate hydrolysis activities, whereas Benito8 identified 17 
biotypes not only based on the previous characteristics but also on fermentation of xylose, arabinose 
and galactose. Phenotypic diversity within G. vaginalis has also been described in terms of virulence 
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factors, particularly production of sialidase10, cytotoxicity7 and ability to adhere and establish a biofilm 
on the vaginal epithelium7,11. Full genome sequencing of different G. vaginalis strains revealed significant 
differences between BV and non-BV isolates 7. This raised the question of whether there are distinct 
pathogenic and commensal lineages within this species. Thus, the present study aimed to isolate BV and 
non-BV associated G. vaginalis strains and to evaluate their virulence potential, using an in vitro bio-
film model, by determining their ability to adhere to epithelial cells, to interfere with the displacement 
of healthy lactobacilli on epithelial cells, to grown as biofilm, to induce cytotoxic changes on epithelial 
cells, to express known virulence genes, and finally by determining their susceptibility to the antibiotics 
commonly used in BV treatment.
Results
Initial adhesion to human cervical HeLa cells and cytotoxic effect. After isolating 7 BV and 7 
non-BV associated strains of G. vaginalis (Supplementary Table S1) we first determined the ability of all 
strains to adhere to a monolayer of HeLa epithelial cells. As can be seen in Fig.  1, variations in adhe-
sion were observed among the 14 isolates, with statistical differences between the 2 groups (p < 0.05). 
Importantly, BV isolates showed a greater ability to adhere to epithelial cells than non-BV isolates, with 
an average of 14.83 and 2.89 bacteria per HeLa cell, respectively. Cytotoxicity was also quantified in order 
to determine the capacity of the 2 groups of bacteria to induce cytotoxic changes in cell morphology 
on HeLa cells. Similar to the initial adhesion assays, BV isolates had a higher cytotoxicity score than 
non-BV isolates (p < 0.05; Fig. 2), which were only capable of causing slight morphological changes in 
HeLa monolayer.
Biofilm formation. In order to determine the optimal medium for in vitro biofilm formation, all 
isolates were initially cultured anaerobically in 9 different media (Supplementary Table S2). As expected, 
G. vaginalis isolates formed different amounts of biofilm, depending on the growth media. To minimize 
the bias introduced by the growth media, we defined the biofilm formation index (BFI) as the average 
of growth in the 3 best growth media. Interestingly, our results showed that there were no significant 
differences in BFI between the 2 groups (p = 0.176), although there was a trend of higher BFI levels 
associated with the BV isolates (Fig. 3).
Antimicrobial susceptibility. In vitro antimicrobial susceptibility of G. vaginalis was evaluated by 
determining the minimal inhibitory concentration (MIC) of metronidazole, tinidazole and clindamy-
cin. Similar to the BFI determinations, no significant differences were found in antimicrobial resist-
ance profiles between non-BV and BV isolates (p = 0.890; Table 1). Interestingly, all G. vaginalis strains 
tested exhibited intermediate resistance or resistance to metronidazole. Similarly, the strains exhibited 
Figure 1. Initial adhesion of non-BV and BV G. vaginalis isolates to HeLa cells. Adhesion was 
microscopically quantified and expressed as the average ± SD number of bacteria per epithelial cell. 
*Denotes significance differences between the 2 groups of G. vaginalis strains at same conditions (one-way 
ANOVA, p < 0.05).
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intermediate resistance or resistance to tinidazole (86% of strains) while only 36% of strains were resist-
ant to clindamycin.
G. vaginalis ability to induce displacement of lactobacilli pre-adhered to epithelial cells. We 
recently reported on the capacity of G. vaginalis to displace adherent vaginal lactobacilli from epithelial 
Figure 2. Cytotoxicity score of non-BV and BV G. vaginalis isolates. Cytotoxicity was scored as follows: 
0, no difference between the experimental well and the control; 1, <25% cells were rounded; 2, 25–50% cells 
were rounded; 3, >50% cells were rounded; 4, >50% were rounded, with partial disruption of the monolayer; 
5, complete disruption/absence of the monolayer. *Values are significantly different between the 2 groups of 
G. vaginalis strains under the same conditions (one-way ANOVA, p < 0.05).
Figure 3. Intrinsic ability of non-BV and BV G. vaginalis isolates to form biofilms. The biofilm formation 
index (BFI) was defined as the average percentage of bacteria grown as biofilms, in the 3 media with 
higher biofilm growth for each G. vaginalis strains. The growth percentage as a biofilm for the 3 media was 
calculated using the equation OD600nm biofilm/ (OD600nm biofilm + OD600nm planktonic) and represented as 
mean ± SD. No significant differences between non-BV and BV isolates were found to BFI (non-parametric 
Wilcoxon matched-pairs rank test, p = 0.176).
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cells12. We sought to determine whether the non-BV and BV strains of G. vaginalis differed in their abil-
ities to displace adherent lactobacilli populations. We found that, on average, BV isolates had a stronger 
ability to cause displacement of L. crispatus (63.78%) than non-BV isolates (19.05%, p = 0.011), as shown 
in Fig. 4. Also, similar to our previous observations12, L. crispatus inhibited the adherence of BV G. vagi-
nalis isolates to the epithelial cells but failed to antagonize the adherence of non-BV isolates.
Presence and expression of virulence genes. To understand the role of virulence genes in non-BV 
and BV isolates of G. vaginalis, we initially determined whether the vaginolysin (vly) and sialidase (sld) 
genes were present in all 14 strains. As shown in table 2, no differences were found between the groups. 
Surprisingly, we verified that vly was absent in strains UM035 and UM224, as determined by PCR amplifi-
cation with 2 independent pairs of primers, contrary to what was been described before7,13. Furthermore, 
this data was confirmed by amplifying and sequencing the flanking regions of vly (Supplementary Fig. 
S1). Since we did not find differences in the presence of these virulence genes between the 2 groups, we 
then analyzed the expression of those genes using a selection of 6 G. vaginalis strains (3 of each group) 
in which all strains carried the 3 genes of interest. Our data revealed differences in the expression of the 
tested genes (Fig. 5). Interestingly, the biggest difference found between the 2 groups was related to vly 
expression, in which BV isolates of G. vaginalis showed, on average, an expression 2-fold higher than 
non-BV isolates (p = 0.045). Nevertheless, no significant differences in expression of sld (p = 0.567) were 
detected between the 2 groups.
Discussion
This study provides a more comprehensive understanding of the different G. vaginalis strains that can 
be found in the vaginal bacterial ecosystem, in health or disease. Clearly, all 7 strains isolated from 
women with BV were more virulent than the 7 non-BV strains. However, contrary to what was previ-
ously hypothesized, this increased virulence was not directly related to biofilm accumulation7, since all 
of our strains had similar biofilm formation, assessed in distinct growth media. On the other hand, the 
higher initial adhesion and cytotoxicity, as well as the ability to displace pre-adherent healthy vaginal 
lactobacilli, were important features of BV associated G. vaginalis, suggesting that the trigger for BV 
development could occur during the early stages of biofilm formation.
G. vaginalis is the most thoroughly studied BV associated microorganism but the fact that it is fre-
quently present in healthy women casts doubt on its role in the etiology of BV1,14. Interestingly, it has 
been reported that certain biotypes of G. vaginalis are more frequently associated with BV9. However, 
functional microbiological studies addressing virulence properties of BV or non-BV strains are still scarce 
and often do not account for strain to strain variability7,12. We designed a series of in vitro experiments to 
Strain
MIC range
Metronidazole Tinidazole Clindamycin
non-BV associated
G. vaginalis UM085 > [128] [16] < [0–01]
G. vaginalis UM061 [16]–[32] [8]-[16] < [0.01]
G.vaginalis UM131 > [128] > [128] > [128]
G.vaginalis UM016 [32] [8]–[16] < [0.01]
G. vaginalis UM094 > [128] [32] [0.5]
G. vaginalis UM060 > [128] > [128] < [0.01]
G. vaginalis UM246 [16]–[32] [16]–[32] > [128]
BV associated
G. vaginalis UM067 [16]–[32] [8]–[16] < [0.01]
G. vaginalis UM121 [32]–[64] [16] > [128]
G. vaginalis UM035 [64]–[128] [4]–[8] < [0.01]
G. vaginalis UM137 [32]–[64] [16]–[32] > [128]
G. vaginalis UM224 [32] [16]–[32] > [128]
G. vaginalis UM241 [32] [2]–[4] < [0.01]
G. vaginalis UM034 > [128] [32]–[64] < [0.01]
Table 1. Minimum inhibitory concentration (MIC) of metronidazole, tinidazole and clindamycin 
for planktonic cells of G. vaginalis isolates. Statistical analysis: no significant differences were found 
in antimicrobial resistance profiles between non-BV and BV associated isolates by the non-parametric 
Wilcoxon matched-pairs rank test (p = 0.890).
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compare the relative virulence capacities of BV and non-BV isolates of G. vaginalis. We used 7 different 
strains per group, to increase the confidence of the results.
We started by quantifying G. vaginalis initial adhesion to HeLa cells, since initial adhesion to the vagi-
nal epithelium is a crucial step in BV development15 and the first step of biofilm formation16. Importantly, 
our data clearly showed that BV isolates adhered more avidly to the epithelial cells. Because the vagina 
is commonly colonized by Lactobacillus species1–3,17, we also explored the interaction between different 
G. vaginalis isolates and protective lactobacilli. The pathogenesis of BV is poorly understood and two 
different chains of events leading to BV have been proposed. One suggests that the population of lac-
tobacilli is drastically reduced, by yet unknown factors, thus allowing the colonization by the multiple 
bacterial species associated with BV, while the other proposes that a single bacterial agent competes with 
lactobacilli, resulting in its overgrowth, later allowing other species to colonize the vaginal epithelium3. 
Recently, we showed that while one BV associated G. vaginalis strain was able to displace a protective 
layer of vaginal lactobacilli and colonize HeLa epithelium cells, this did not occur with a non-BV strain12. 
To confirm those findings, we analysed the ability of the G. vaginalis panel used in this study to displace 
L. crispatus previously adhered to the HeLa cells. Strengthening our previous observations, only BV 
associated strains of G. vaginalis were able to displace around 80% of the pre-coated lactobacilli (5 out 
Figure 4. Influence of L. crispatus on G. vaginalis initial adhesion to HeLa cells. L. crispatus was pre-
adhered to the epithelial cells. Subsequently, each G. vaginalis strain was added. (A) represents the non-BV 
isolates. (B) represents the BV isolates. Results are expressed as mean ± SD of bacteria/HeLa cell. The 
percentage indicated is the result of the variation in the final adhesion of L. crispatus and G. vaginalis, 
after G. vaginalis challenge to the pre-coated L. crispatus, as compared to the adhesion levels of each strain 
independently. *Values are significantly different from the respective control (independent samples t-test, 
p < 0.05). **Significant differences in the displacement of L. crispatus by two groups of G. vaginalis strains 
were found (one-way ANOVA, p = 0.011). No significant differences in the adherence of G. vaginalis were 
found between non-BV and BV isolates when mixed with L. crispatus (one-way ANOVA, p = 0.120).
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of 7 strains). On the other hand, L. crispatus had a more pronounced effect in impeding the colonization 
by BV associated G. vaginalis. This data suggests that BV associated variants of G. vaginalis could be 
the primary pathogens in BV development, since this subset of strains have the ability to significantly 
displace vaginal lactobacilli, supporting one of the BV development models proposed3.
We also analyzed the ability of G. vaginalis to cause cytopathogenic changes in HeLa epithelial cells. 
We found that the BV isolates were significantly more cytotoxic, inducing rounding and lysis of HeLa 
epithelial cells, while non-BV G. vaginalis were unable to cause such cytopathogenic changes. The cyto-
toxicity activity of BV isolates could be due to a pore-forming toxin produced by G. vaginalis, vagino-
lysin, which is able to induce cell death and is thus a virulence factor13. Interestingly our data revealed 
that on average, BV isolates expressed 2-fold more vly than non-BV strains. However, strain to strain 
variability suggests that vly expression is not exclusive of BV associated G. vaginalis. Furthermore, sial-
idase could increase the cytotoxic activity of G. vaginalis and contribute to exfoliation and detachment 
of vaginal epithelial cells, by degrading mucins, which normally protect the epithelium10. Our studies 
did not reveal a direct relationship between sialidase expression and cytotoxicity, however, the epithelial 
Strain
Presence of virulence genes
vly sld
non-BV associated
G. vaginalis UM085 + + 
G. vaginalis UM061 + + 
G. vaginalis UM131 + + 
G. vaginalis UM016 + + 
G. vaginalis UM094 + –
G. vaginalis UM060 + + 
G. vaginalis UM246 + + 
BV associated
G. vaginalis UM067 + + 
G. vaginalis UM121 + + 
G. vaginalis UM035 – + 
G. vaginalis UM137 + + 
G. vaginalis UM224 – –
G. vaginalis UM241 + + 
G. vaginalis UM034 + –
Table 2.  Detection by PCR of the vly and sld genes in G. vaginalis isolates.
Figure 5. Expression of vaginolysin (vly) and sialidase (sld) by G. vaginalis isolates. Transcript levels 
within planktonic culture of the G. vaginalis strains were quantified. Results are expressed as normalized 
expression in relation to 16S rRNA and represented as mean ± SEM. *Values are significantly different 
between non-BV and BV G. vaginalis strains to vly gene expression (one-way ANOVA, p = 0.045). No 
significant differences between two groups were found to sld gene expression (one-way ANOVA, p = 0.567).
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monolayers used in our model do not produce mucins. Therefore, a different model system would be 
required to test this hypothesis.
It has also been described that as BV progresses, a highly structured polymicrobial biofilm develops 
on the vaginal epithelium and a major component of the biofilm is G. vaginalis11,15,18–20. Taking into 
consideration the differences in adhesion to epithelial cells, and the fact that initial adhesion does not 
always correlate to biofilm accumulation21, we characterized the intrinsic ability of G. vaginalis strains to 
grow as biofilms. Curiously, in our in vitro assay, BV isolates generally presented a higher BFI, however, 
differences in biofilm formation between the 2 groups did not reach statistical significance. Nevertheless, 
only 5 out of 7 non-BV isolates were able to grow preferentially as a biofilm (BFI > 50%) while all 7 BV 
isolates analyzed showed a BFI > 50%. Biofilm formation is an important virulence factor because it con-
fers increased tolerance to antibiotics22 and antimicrobial byproducts produced by lactobacilli normally 
associated with the healthy vagina18. Importantly, we detected high levels of antimicrobial resistance 
in all isolates analyzed, confirming our previous reports4. Surprisingly, similar to the biofilm assay, no 
differences were detected between the two groups. Overall, G. vaginalis strains were more susceptible to 
clindamycin than to metronidazole or tinidazole, which was unexpected based on previous reports23,24.
This work clearly demonstrates strain differences between G. vaginalis isolates that could impact the 
ability of this organism to cause disease. However, the in vitro model of adherence used in this study is 
limited by the fact that cell monolayers of HeLa cells are not polarized, as are vaginal epithelial cells in 
vivo. The assay for biofilm formation was limited by the fact that the growth medium did not contain 
all of the factors found in vivo, and some in vivo cues may turn on expression of biofilm-related genes. 
Nevertheless, these limitations aside, in vitro models can be very informative, and are key to furthering 
our understanding of virulence potential of G. vaginalis.
Taking in consideration our novel findings and our previous observations4,12,25,26 we hypothesize that 
colonization by a subset of G. vaginalis is the trigger for BV development. By displacing lactobacilli, 
adhered G. vaginalis will then start to form a biofilm that will subsequently promote the incorporation of 
secondary colonizers and this mixed biofilm will ultimately become recalcitrant to antimicrobial therapy, 
similar to what has been described for oral biofilms27. Future genomic characterization of the non-BV 
and BV isolates of G. vaginalis will unveil the molecular mechanisms involved in these reported virulence 
differences. We envision that this will later impact novel diagnostic procedures and therapeutic options 
to treat BV.
Methods
Subject selection and sample collection. Vaginal samples were obtained from volunteers during 
private gynecology consult. All sampling was conducted in accordance with relevant guidelines and 
regulations and research approved by the University of Minho Institutional Review Board (approval 
number: SESVC 003-2013) in accordance with the Declaration of Helsinki and the guidelines of Good 
Clinical Practice. Written informed consent was obtained from all study participants prior to enrolment. 
Women were excluded from the study if they had any chronical disease. Classification of samples was 
done as before28. Briefly, BV diagnosis was first performed by the clinician, using the Amsel criteria29. 
Then based on the criteria for BV assessment developed by Nugent et al.30, participants with the Gram 
stain score of ≥ 7 were finally confirmed as BV (Supplementary Table S3). We also probed the samples 
with a novel PNA-FISH probe against G. vaginalis31.
Bacterial isolation and identification. The presence of G. vaginalis in vaginal samples was further 
confirmed by PCR using an optimized protocol, as we previously described32. Samples positive for G. 
vaginalis were plated in columbia blood agar medium (Liofilchem, Roseto degli Abruzzi, Italy) with 
5% (v/v) defibrinated horse blood (Oxoid Ltd., Basingstoke, Hants, United Kingdom) and incubated 
under anaerobic conditions, as described before4,33. Isolated bacteria were analyzed by Gram stain and 
subsequently identified by partial sequencing of 16S rRNA coding gene as described before34 (Eurofins, 
Germany). Nucleotide sequences obtained were compared to known sequences through BLAST software 
(NCBI, Bethesda, MD, USA). The primers used are listed in Supplementary Table S4. The accession 
number for these 14 strains are listed in Supplementary Table S1.
Initial adhesion to epithelial cells and cytotoxicity assays. Initial adhesion to human cervical 
HeLa cells (ATCC CCL-2) and cytotoxicity assays were performed as described previously4. Briefly, for 
the adhesion assays, blind bacterial suspensions with a concentration of 1 × 108 colony-forming units 
(cfu)/mL were added to a monolayer of HeLa cells for 30 minutes at 37 °C under anaerobic conditions. 
After washing the non-adherent bacteria, cells were fixed with methanol and adhesion was microscop-
ically quantified as we previously described4. For the cytotoxicity assays, blind bacterial suspensions 
adjusted to 2.9 × 107 cfu/mL were added to a monolayer of HeLa cells for 3 hours. Cytotoxicity was 
scored on a 0 to 5 scale18. Numeric scores were assigned as follows: 0, no difference between the test and 
the control; 1, 25% of the cells were rounded; 2, 25–50% of the cells were rounded; 3, 50% of the cells 
were rounded; 4, 50% cells were rounded, with partial disruption of the monolayer; and 5, complete 
disruption or absence of the monolayer. All experiments were performed in triplicate with technical 
replicates.
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Quantification of biofilm formation. Bacteria were grown in 9 different commercially available 
culture media, commonly used for biofilm growth: LB [composed by 10 g/L Tryptone (Liofilchem), 5 
g/L yeast extract (Liofilchem) and 10 g/L of NaCl (Liofilchem)], MRS (Liofilchem), TSB (Liofilchem), 
sBHI [BHI (Liofilchem) supplemented with 2% (w/w) gelatin (Oxoid), 0.5% (w/w) yeast extract, 0.1% 
(w/w) starch (Thermo Fisher Scientific, Lenexa, KS, USA )], sBHIF [sBHI with 10% (v/v) FBS], and 
finally LBG, MRSG, TSBG and sBHIG supplemented with 0.25% (w/v) of glucose (Liofilchem)4. Biofilm 
formation assays were performed as described previously7,18. In brief, 200 μ L of each bacterial suspension 
adjusted to 1 × 106 cfu/mL was incubated in 96-well flat-bottom tissue culture plates (Orange Scientific, 
Braine L’Alleud, Belgium) at 37 °C for 48 hours under anaerobic conditions. Biofilms were first qualita-
tively evaluated with safranin staining18. Subsequently, the intrinsic ability of G. vaginalis strains to grow 
as biofilms was quantified, using the equation Optical Density (OD)600nm biofilm / (OD600nm biofilm + 
OD600nm planktonic) as described by Harwich et al.7, for the 3 media that promoted the greatest biofilm 
growth. The biofilm formation index (BFI) was defined as the average biofilm quantity in the 3 selected 
growth media4. All assays were repeated 3 times with technical replicates.
Antibiotic susceptibility. The susceptibility of G. vaginalis to antibiotics was evaluated by deter-
mining the minimal inhibitory concentration (MIC) of metronidazole, tinidazole and clindamycin. A 
pre-culture was first prepared for each isolate in sBHI by incubating at 37 °C under anaerobic conditions. 
After 24 hours, growth was confirmed by measuring the OD at 600 nm. MIC was determined by microdi-
lution method in 96-well tissue culture plates35. All assays were repeated 3 times with technical replicates.
G. vaginalis ability to induce displacement of lactobacilli pre-adhered to epithelial cells. The 
ability of G. vaginalis to displace Lactobacillus crispatus pre-adhered to epithelial cells was assessed using 
a protocol that we previously optimized12 with minor changes. Briefly, a suspension of 1.0 × 109 cfu/mL 
of L. crispatus EX533959VC06 was added to each well of the 24-well plate containing the monolayer of 
HeLa cells. The plates were incubated for 4 hours at 37 °C in anaerobic conditions, at 0.081 g (PSU-10i, 
Biosan, Latvia). Subsequently, G. vaginalis strains (1.0 × 108 cfu/mL) were added for 30 minutes under 
the same conditions as described above. Bacterial quantification was done as previously described36.
PCR detection of virulence genes. Oligonucleotide primers for the detection of vly and sld genes 
were designed using the Primer3 software37 using the complete genome of G. vaginalis strain ATCC 14019 
as a template. The 16S rRNA was used as internal control. Negative PCR results were confirmed using 
a second pair of independent primers. All primers used are listed in Supplementary Table S4. Genomic 
DNA was extracted as described before32 and the thermocycling program (Mini-MJ, Bio-Rad, Hercules, 
CA, USA) was performed using the DreamTaq PCR Master Mix 2x (Finnzymes, Espoo, Finland) and 
consisted on the following steps: 94 °C for 2 minutes followed by 40 cycles of 94 °C for 30 seconds, 58 °C 
for 30 seconds, 72 °C for 60 seconds and finally 72 °C for 5 minutes. The PCR product was then kept hold 
at 4 °C. PCR products were analyzed by gel electrophoresis with 1.5% agarose (Bioron, Ludwigshafen, 
Germany) and Orange G DNA loading dye (Thermo Fisher Scientific). All assays were repeated 3 times.
Gene expression quantification. G. vaginalis strains were grown as described for the adhesion 
assays. Total RNA was extracted as previous described38. Briefly, genomic DNA was degraded with one 
step of DNase treatment (Fermentas, Lithuania) following manufacturer’s instructions. RNA concentra-
tion, purity and integrity was determined as described before39. Quantitative PCR (qPCR) was performed 
as previously described38 with some modifications. Briefly, qPCR was done using a CFX96TM thermal 
cycler (Bio-Rad) with the following cycling parameters: 3 minutes at 95 °C, followed by 45 cycles of 10 
seconds at 95 °C, 10 seconds at 58 °C and 15 seconds at 72 °C. The primer efficiency and the normalized 
gene expression was determined by using the delta Ct method (2ΔCt), a variation of the Livak method, 
where Δ Ct = Ct (reference gene) – Ct (target gene). All primer pairs had similar efficiencies. A control 
lacking the reverse transcriptase enzyme was included in each reaction. Gene expression assays were 
performed 3 independent times and in each time we had 3 qPCR wells per gene.
Statistical analysis. The data were analyzed using the independent samples t-test, one-way analysis 
of variance (ANOVA), or non-parametric Wilcoxon matched-pairs rank test for the data that did not 
follow a normal distribution according Kolmogorov-Smirvon’s test, with the statistical software package 
SPSS 17.0 (SPSS Inc. Chicago, IL). The data were represented as mean ± standard deviation (SD) or as 
mean ± standard error of mean (SEM) at least 3 independent experiments. P-values of less than 0.05 
were considered significant.
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